The London Discount: Five Deals Defining - UK M&A in 2025–2026
Recently, the UK markets have been seen as undervalued, and the world has begun to notice. The defining theme in UK M&A was foreign appetite with deal values rising even as the number of transactions fell, because overseas buyers paid heavily for the few assets they wanted.
Recently, the UK markets have been seen as undervalued, and the world has begun to notice. The defining theme in UK M&A was foreign appetite with deal values rising even as the number of transactions fell, because overseas buyers paid heavily for the few assets they wanted. The clearest case was Qualcomm‘s £1.8bn acquisition of British chip designer Alphawave, whose high speed connectivity technology is vital for AI data centres yet was priced in London well below what a US buyer would pay for it. The pattern now repeats across the market, with American acquirers paying GBP prices that still look like a discount once converted into dollars.
This can be explained structurally. UK companies trade at a discount because the domestic investors who once supported them have largely gone. British pension funds now hold barely 4% of their money in UK equities, far below the level of a generation ago, so prices have little holding them up. That discount is what keeps drawing bidders. Recently a US rival tabled a £2.7bn offer for the British food ingredients group Tate and Lyle, and its shares jumped 45% on the news, a sign of how far below fair value it had been sitting. M&A has now become the main way companies leave the London market.
However, 2026 has better signs for M&A activity. With inflation falling back towards target and rates coming down, the cost of financing a deal is now lower. Reformed listing rules are also meant to make London easier to float in. In our opinion, the rebound is genuine but fragile. Until London fixes why its own companies trade so cheaply, that discount will keep inviting bidders, and Britain stays a target rather than a base.
ENGIE / UK Power Networks
In February 2026, French utility giant ENGIE agreed to acquire UK Power Networks (UKPN), the UK‘s largest electricity distribution operator, for an equity value of £10.5bn and an enterprise value of approximately £15.8bn. The deal represents one of the largest UK infrastructure transactions in recent years and reflects the growing strategic importance of electricity networks as countries accelerate electrification and decarbonisation efforts. UKPN operates around 192,000km of power lines, distributes roughly 71TWh of electricity annually, and serves 8.5 million customers across London, the South East and East of England.
Strategically, the acquisition gives ENGIE large scale in one of Europe‘s most attractive regulated energy markets. Rather than building a presence from scratch, ENGIE gains ownership of a major infrastructural piece that will be central to the UK‘s net-zero transition. Politically, the transaction highlights Britain‘s continued willingness to allow foreign ownership of strategic infrastructure assets. While some may question another major UK asset being acquired by an overseas buyer, the government‘s ambitious decarbonisation targets require substantial private investment, making foreign capital increasingly important.
Financially, the deal provides ENGIE with stable, regulated and inflation-linked revenues, improving the group‘s risk profile and reducing its reliance on volatile energy markets. The company plans to finance the acquisition through debt, equity issuance and asset disposals, demonstrating its confidence in the long-term returns available from electricity networks.
In our view, the acquisition makes strong strategic and financial sense. Demand for electricity is expected to rise significantly as EV adoption, and renewable generation expand. The deal also demonstrates how ownership of energy infrastructure is becoming one of the most valuable themes in global investing.
Nuveen / Schroders
Also in February of this year, US-based asset manager Nuveen agreed to acquire the 222-year-old British firm Schroders in a £9.9bn deal, creating one of the world‘s largest active asset managers with nearly $2.5 trillion in AUM. This transaction signals the growing pressure on asset managers to consolidate or be left behind. The combination of rising fee pressure, the continued shift to passive investing, and increasing demand for private market solutions is forcing firms to seek scale or risk irrelevance.
Strategically, the deal expands Nuveen‘s geographical reach while strengthening its capabilities, particularly in infrastructure and private credit, where client demand has grown fastest. Schroders Capital and Hargreaves Lansdown have already partnered to offer UK retail investors access to high-growth private market investments. This gives Nuveen an established institutional investment business and an early foothold in retail private markets distribution. Financially, it offers revenue synergies through cross-selling across a global client base, alongside cost synergies from consolidating overlapping back-office and infrastructure functions.
The deal also reflects a broader structural shift in capital away from London, with this being another case of a US acquirer absorbing a British institution. More broadly, it is a clear marker of where the active management industry is heading. Mid-scale firms like Schroders are caught in the middle: too large to be niche, yet too small to match the giants. This acquisition makes sense but it might also signal some deeper concerns for London and the wider asset manager industry.
Zurich / Beazley
Following months of protracted negotiations, Zurich Insurance Group secured its £8.1bn all-cash acquisition of London-based specialist insurer Beazley in March 2026. The breakthrough came after Beazley declined multiple bids throughout 2025, finally coming to an agreement with enhanced terms. In an industry where specialised underwriting, vast data access and deep client relationships are critical, this transaction adds to Zurich‘s competitive edge whilst also restricting rivals‘ expansion opportunities.
By absorbing Beazley, Zurich accelerates its specialty insurance strategy. Beazley brings unmatched depth in cyber insurance, a top-tier position in the US Excess and Surplus (E&S) lines and a presence within the Lloyd‘s of London market. The strategic logic for Zurich is in connecting Beazley‘s niche underwriting expertise and data capabilities with its own massive global balance sheet and distribution network, allowing the combination to tackle an increasingly complex and interconnected risk landscape. Synergies are expected to come through reinsurance optimisation, cross-selling products across a broader client base and cost savings through economies of scale in technology, compliance and distribution.
Beazley‘s sale marks yet another prominent UK financial institution being acquired by a foreign buyer. While Zurich has committed to keeping the combined specialty business headquartered in London and retaining the Beazley brand, this acquisition continues to fuel concerns about the long-term independence and centre-of-gravity of the London market. The deal is entirely rational as Zurich gets a world-class cyber underwriter, a Lloyd‘s platform and a data-rich company which would have taken years to build alone. For Beazley it was a great deal since it preserved its leadership and brand with the board having the discipline to reject early offers till their price was met.
Ingredion / Tate & Lyle
After a challenging five years, Tate & Lyle‘s future looks considerably sweeter. In May, shares in the ingredients group jumped more than 45% after US-listed Ingredion announced a £2.7bn takeover bid. While the transaction would create one of the largest global ingredients groups and increase Ingredion‘s geographic reach, the strategic rationale appears to be less about scale than combined capabilities.
The food and beverage industry is undergoing a structural shift toward healthier, higher-protein, higher-fibre, and lower-sugar products, without compromise on taste, texture or convenience. This trend is reinforced by adoption of GLP-1 medications. Food manufacturers are responding by reformulating products, accelerating demand for innovative ingredients that can meet multiple nutrition requirements simultaneously.
Despite weaker discretionary spending amid cost-of-living pressures, health and wellness remains a resilient category in food and beverages. Consumers are often willing to pay a premium for products offering nutritional benefits. As a result, growth is increasingly driven by higher-priced and higher-margin products rather than sales volume.
Tate & Lyle is well-positioned to capitalise on this shift, having recently undergone a significant strategic pivot from primarily sweeteners into a broader range of higher-margin speciality ingredients. In particular, its 2024 acquisition of CP Kelco expanded its capabilities to include pectin, gums, and other texture and stabilisation techniques.
Ingredion brings complementary strengths in clean-label ingredients, texturants and plant-based proteins. The combination of groups would enhance their product portfolio and accelerate product development in higher-growth categories.
Notably, Ingredion‘s offer is the first public approach but not the first private approach. This suggests Ingredion has viewed Tate & Lyle as an attractive target for some time, but the current market conditions present an ideal opportunity. Other recent events also reflect this trend, including Nexture‘s acquisition of Frulact, and Nestlé repositioning itself into health and wellness through multiple acquisitions, and Kraft Heinz restructuring to better target health-conscious customers in a separate company. Looking ahead, the ingredients sector is likely to see sustained M&A activity as companies reposition toward health and wellness.
Sony / STATSports
In October last year, Japanese technology and entertainment giant Sony acquired a majority stake in STATSports, the Northern Irish athlete-tracking firm founded in 2008, in a deal whose terms were left undisclosed. The acquisition folds one of Britain‘s leading sports-technology innovators into Sony‘s growing sports data division, signalling the accelerating convergence of technology, sport and entertainment.
STATSports is best known for its GPS wearable systems, which capture more than 70 real-time performance metrics and are trusted by over 800 elite organisations, including Arsenal, Liverpool, PSG, the England national team and the All Blacks. For Sony, the appeal is strategic rather than purely financial. The deal slots neatly alongside its existing assets like Hawk-Eye‘s optical tracking, KinaTrax‘s biomechanics and Beyond Sports‘ visualisation, letting it pair wearable data with camera-based systems to build what management has called the „ultimate sports data and analytics engine.“ The prize is a single, integrated platform spanning performance analysis, officiating and fan engagement.
Strategically, this gives Sony a defensible foothold in a fast-growing market and a wealth of proprietary athlete data; for STATSports, it brings the global distribution and R&D firepower needed to scale at pace.
However, the deal also fits a now-familiar pattern: another homegrown British firm being purchased by an overseas acquirer. STATSports built a world-leading product out of Northern Ireland, only to be scaled under foreign ownership rather than as a domestic firm. The commercial logic is sound, but it asks the same questions of the UK: whether it can retain and grow its best technology businesses, or simply create them for others.
Outlook
The five deals covered in this edition trace a single arc. Regardless of the industry, the story is the same. World-class British businesses attracting serious overseas capital at prices that still look cheap to foreign buyers.
The structural cause is well understood. British pension funds have largely withdrawn from domestic equities, removing the long-term holders that once supported valuations. Until that capital returns, the discount will persist, and so will the bids.
2026 is a better environment than the years prior. Rates are falling, financing is cheaper, and listing rules have been reformed. In our opinion, that is enough to sustain a rebound in activity, but not enough to fix the underlying issue. A market that loses its best companies at a discount is not recovering. Britain, for now, remains a target.
